Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|5|836-845

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.5, 2014-06, pp. : 836-845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Recent Development of 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2134-2151

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia

By Wallace Tanya L.   Bertrand Daniel  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 139-155

Informa Healthcare

Access to resources Recommend Favorite

ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-09 ,pp. : 193-210

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Nogo Receptor Complex in Diseases of the Central Nervous System

By  

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 234-244

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 2, 2017-07 ,pp. : 100-108

Bentham Science Publishers

Access to resources Recommend Favorite